BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6354238)

  • 1. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
    Shabana AH; Ivanyi L; Kramer IR
    Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
    Dabelsteen E; Clausen H; Holmstrup P; Reibel J
    APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGE-A antigens in lesions of the oral mucosa.
    Krauss E; Rauthe S; Gattenlöhner S; Reuther T; Kochel M; Kriegebaum U; Kübler AC; Müller-Richter UD
    Clin Oral Investig; 2011 Jun; 15(3):315-20. PubMed ID: 20174843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
    Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
    Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Ca 1 monoclonal antibody in distinguishing oral squamous cell carcinoma from non-malignant or premalignant oral lesions.
    Masouredis CM; Green TL; Greenspan JS
    J Oral Pathol; 1987 Jul; 16(6):307-9. PubMed ID: 3119804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.
    Tsuji T; Shrestha P; Yamada K; Takagi H; Shinozaki F; Sasaki K; Maeda K; Mori M
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):377-83. PubMed ID: 1375793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate changes in squamous cell carcinomas.
    Dabelsteen E; Clausen H; Mandel U
    APMIS Suppl; 1992; 27():130-8. PubMed ID: 1520522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
    Dabelsteen E; Graem N; Hakomori S; Young WW
    Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
    Nitta T; Sugihara K; Tsuyama S; Murata F
    Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions.
    Huang WY; Coltrera M; Schubert M; Morton T; Truelove E
    Oral Surg Oral Med Oral Pathol; 1994 Dec; 78(6):748-54. PubMed ID: 7534896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
    Löning T
    Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
    Girod SC; Kühnast T; Ulrich S; Krueger GR
    In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal antibodies 17.13 and 63.12 with 141 oral mucosal lesions.
    Migliorati CA; Ranken R; Kaplan MJ; Silverman S
    J Oral Pathol Med; 1992 Oct; 21(9):412-7. PubMed ID: 1279163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa.
    Burkhardt A
    J Oral Pathol; 1985 Nov; 14(10):751-78. PubMed ID: 2414422
    [No Abstract]   [Full Text] [Related]  

  • 15. Epithelial isoantigens A, B and H in oral carcinomas.
    Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
    Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered H-antigen reactivity as an early indicator of malignant transformation in oral epithelium.
    Auclair PL
    J Oral Pathol; 1984 Aug; 13(4):401-11. PubMed ID: 6432985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of a blood group antigen precursor in oral premalignant lesions.
    Dabelsteen E; Vedtofte P; Hakomori S; Young WW
    Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of expression of 5T4 antigen in cervical cancer.
    Jones H; Roberts G; Hole N; McDicken IW; Stern P
    Br J Cancer; 1990 Jan; 61(1):96-100. PubMed ID: 2404512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of blood group H antigen by normal, benign, and carcinoma cells of the oral epithelium: immunohistochemical study using monoclonal antibody RS13.
    Shabana AH; Lubenko A; Ivanyi L
    Oral Surg Oral Med Oral Pathol; 1986 Nov; 62(5):532-7. PubMed ID: 3537896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.